The Rainbow Study - the Effect of Feedback on Asthmatic Symptom Perception
NCT ID: NCT06702735
Last Updated: 2024-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
39 participants
INTERVENTIONAL
2023-10-16
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A tool was developed to visualize symptoms, lung function and accessory symptom perception: The Rainbow tool. The aim of this study was to identify asthmatic children with a poor perception and investigate if their symptom perception could be improved by regular lung function measurements and personal feedback based on the Rainbow Tool.
Hypothesis: Measuring lung function en symptoms and provide personal feedback on perception based on the Rainbow tool has a positive effect on perception of asthma-related symptoms in asthmatic children.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Instrument Utility for Suspected Asthma (0000-042)(COMPLETED)
NCT00211575
Childhood Asthma Perception Study
NCT02702687
Progression of Airway Obstruction in Childhood Asthma
NCT00873873
A Multifaceted Prompting Intervention for Urban Children With Asthma
NCT01105754
Asthma Inpatient Research on Education
NCT02948738
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A tool was developed to visualize symptoms, lung function and accessory symptom perception: The Rainbow tool. The Rainbow tool is a two-dimensional color-coded plot, visualizing the relationship between lung function, denoted as a percentage of personal best (FEV1) on the vertical axis, and VAS score on the horizontal axis. The FEV1 as a percentage of personal best on the vertical axis ranges from 30% to 100% since a maximal VAS score would be expected with a change in FEV1 to ≤ 30% of personal best. The horizontal axis ranges from 0 to 10, with 0 indicating no dyspnea and 10 maximal dyspnea. There are four color-coded zones: the green zone, yellow zone, orange zone, and red zone. The green zone indicates good alignment between symptoms and lung function, and thus a good symptom perception. It forms a diagonal band from the upper left (around 100% FEV1 and VAS score of 0) stretching to the lower right (around 30% FEV1 and VAS score of 10). The green zone is followed by the yellow, orange, and red zones on either side, indicating an increasing deviation in symptom perception from the ideal and respectively mild, moderate, and severe disconcordance between FEV1 and VAS score. The aim of this study was to identify asthmatic children with a poor perception and investigate if their symptom perception could be improved by regular lung function measurements and personal feedback based on the Rainbow Tool.
Hypothesis: Measuring lung function en symptoms and provide personal feedback on perception based on the Rainbow tool has a positive effect on perception of asthma-related symptoms in asthmatic children.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group (with feedback)
Collection of VAS scores and lung function. Explanation about the Rainbow tool to visualize symptom perception, and use of this tool during intervention phase. Feedback sessions with health care professional to evaluate symptom perception using the Rainbow tool.
Rainbow tool
The Rainbow tool visualizes perception based on lung function measurements and VAS scores.
Feedback
Feedback sessions with health care professional based on the Rainbow tool.
Intervention group (without feedback)
Collection of VAS scores and lung function. Explanation about the Rainbow tool to visualize symptom perception, and use of this tool during intervention phase.
Rainbow tool
The Rainbow tool visualizes perception based on lung function measurements and VAS scores.
Control group
Collection of VAS scores and lung function. No additional intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rainbow tool
The Rainbow tool visualizes perception based on lung function measurements and VAS scores.
Feedback
Feedback sessions with health care professional based on the Rainbow tool.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pediatrician diagnosed asthma
* Health care professional thinks perception might be poor
* Age 7 until 15 years old
* Adequate understanding of Dutch language
Intervention phase:
* Adequate number of lung function measurements + VAS scores during selection phase, defined as:
* At least 4 measurements after exercise or when experiencing symptoms and
* At least 2 standard measurements
* Poor perception during selection phase, defined as:
* At least 1 measurement in red zone on Perception Rainbow and/or
* At least 2 measurements in orange zone on Perception Rainbow and/or
* Average of all measurements after exercise or when experiencing symptoms in yellow zone (or orange/red)and/or
* Average of all measurements in yellow zone (or orange/red)
Exclusion Criteria
* Not able to fill in VAS score (for example due to blindness)
* Not able to perform technically correct spirometry manoeuvres
* Medication change in past 2 weeks
* Exacerbation which required oral prednisone in the past 6 weeks
* Exacerbation at the moment of inclusion
* No device (computer, tablet or smartphone) with internet connection available at home
7 Years
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medisch Spectrum Twente
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vera Hengeveld, MD
Role: PRINCIPAL_INVESTIGATOR
Medisch Spectrum Twente
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medisch Spectrum Twente
Enschede, Overijssel, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RAINBOW study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.